(161 180)eso 1

From Encyclopedia & World Directory
Jump to navigation Jump to search

 - a recombinant 19 residue peptide vaccine consisting of amino acids 161 through 180 of the cancer/testis (ct) antigen. Eso 1 (161 180) peptide vaccine may stimulate the host immune system to mount a cytotoxic t lymphocyte (ctl) response against tumor cells positive for eso 1, resulting in decreased tumor growth. Eso 1 is expressed in a variety of cancers, including melanoma, breast, bladder, prostate, and hepatocellular cancers. (nci04)

Latest research

External links[edit source]

Wikipedia

Latest articles - (161 180)eso 1[edit source]

PubMed
Clinical trials
UpToDate

Source: Data courtesy of the U.S. National Library of Medicine. Since the data might have changed, please query MeSH on (161 180)eso 1 for any updates.


Navigation: Wellness - Health Encyclopedia - Health topics - Disease Index‏‎ - Cases - Drugs - Rare diseases - Gray's Anatomy - USMLE - All Pages

World directories: Doctors - Healthsites - Hospitals - Medical schools

WikiMD's articles are provided for informational purposes, and is not a substitute for professional medical advice. See full disclaimer.

Tired of being Overweight? Want to lose weight with insurance?
Try W8MD's physician weight loss - Philadelphia weight loss & NYC lose weight.